Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|January 1, 2010
Cardiovascular disease: what's all the AGE/RAGE about?Drazenka P Barlovic, Merlin C Thomas, Karin Jandeleit-Dahm
American Journal of Therapeutics|November 11, 2005
Advanced glycation end products and diabetic nephropathyMerlin C Thomas, Josephine M Forbes, Mark E Cooper
Atherosclerosis|September 6, 2012
Angiotensin converting enzyme 2 and atherosclerosisYutang Wang, Chris Tikellis, Merlin C Thomas, et al.
Cell Metabolism|February 8, 2023
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetesMerlin C Thomas, Melinda T Coughlan, Mark E Cooper
Kidney International|September 17, 2005
Targets to retard the progression of diabetic nephropathyMark E Cooper, Karin Jandeleit-Dahm, Merlin C Thomas
Diabetes, Obesity & Metabolism|July 3, 2018
Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetesValma Harjutsalo, Merlin C Thomas, Carol Forsblom, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2006
The epidemiology of hemoglobin levels in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard J MacIsaac, et al.
Kidney International|March 13, 2003
Dialysis delayed is death prevented: a clinical perspective on the RENAAL studyMerlin C Thomas, Mark E Cooper, Shahnaz Shahinfar, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
Role of advanced glycation end products in diabetic nephropathyJosephine M Forbes, Mark E Cooper, Matthew D Oldfield, et al.
Archives of Internal Medicine|March 2, 2005
Anemia with impaired erythropoietin response in diabetic patientsMerlin C Thomas, Mark E Cooper, Con Tsalamandris, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Cardiovascular & Hematological Disorders Drug Targets|January 1, 2010
Cardiovascular disease: what's all the AGE/RAGE about?Drazenka P Barlovic, Merlin C Thomas, Karin Jandeleit-Dahm
American Journal of Therapeutics|November 11, 2005
Advanced glycation end products and diabetic nephropathyMerlin C Thomas, Josephine M Forbes, Mark E Cooper
Atherosclerosis|September 6, 2012
Angiotensin converting enzyme 2 and atherosclerosisYutang Wang, Chris Tikellis, Merlin C Thomas, et al.
Cell Metabolism|February 8, 2023
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetesMerlin C Thomas, Melinda T Coughlan, Mark E Cooper
Kidney International|September 17, 2005
Targets to retard the progression of diabetic nephropathyMark E Cooper, Karin Jandeleit-Dahm, Merlin C Thomas
Diabetes, Obesity & Metabolism|July 3, 2018
Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetesValma Harjutsalo, Merlin C Thomas, Carol Forsblom, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2006
The epidemiology of hemoglobin levels in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard J MacIsaac, et al.
Kidney International|March 13, 2003
Dialysis delayed is death prevented: a clinical perspective on the RENAAL studyMerlin C Thomas, Mark E Cooper, Shahnaz Shahinfar, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
Role of advanced glycation end products in diabetic nephropathyJosephine M Forbes, Mark E Cooper, Matthew D Oldfield, et al.
Archives of Internal Medicine|March 2, 2005
Anemia with impaired erythropoietin response in diabetic patientsMerlin C Thomas, Mark E Cooper, Con Tsalamandris, et al.
Pageof 18